Doxercalciferol (Compound)

Synonyms:Doxercalciferol, 54573-75-0, Hectorol, 1alpha-Hydroxyergocalciferol, 1-Hydroxyergocalciferol, TSA 840, 1alpha-hydroxyvitamin D2, 1-alpha-Hydroxyvitamin D2, 1-Hydroxyvitamin D2, UNII-3DIZ9LF5Y9, (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol, 3DIZ9LF5Y9, 1-alpha-hydroxyergocalciferol, CHEBI:4712, (1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol, MFCD00871065, 1alpha-hydroxyvitamin D2 / 1alpha-hydroxyergocalciferol, (5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3-diol, Hectorol (TN), (1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol, 1alpha-OHD2, BRN 4716774, Doxercalciferol [USAN:INN], Doxercalciferolum, NCGC00182058-03, 1alphaOHD2, 1a-hydroxyvitamin D2, 1alpha-hydroxy vitamin D2, (5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol, 1-alpha-hydroxy-vitamin D2, DSSTox_CID_14214, DSSTox_RID_79125, 1.alpha.-Hydroxyvitamin D2, Doxercalciferol (USAN/INN), DSSTox_GSID_34214, SCHEMBL322422, GTPL2790, CHEMBL1200810, DTXSID1034214, TSA-840, ACT06836, EX-A4428, ZINC4641374, Tox21_112978, HSCI1_000341, LMST03010028, AKOS005146517, CS-0395, DB06410, 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1-alpha,3-beta,5Z,7E,22E)-, BS-17040, GZ427397, HY-32348, CAS-54573-75-0, V1826, C08211, D01009, 42163-EP2298768A1, 42163-EP2311808A1, 42163-EP2311829A1, 573D750, Q5303688, Doxercalciferol, >=98% (HPLC), solubility: >10 mg/mL in DMSO, Doxercalciferol, United States Pharmacopeia (USP) Reference Standard, 9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol, (1alpha,3beta,5Z,7E,22E)-, (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7?-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol, (1R,3S,5Z)-4-Methylene-5-[(2E)-2-[(1R,3aS,7aR)-octahydro-7alpha-methyl-1-[(1R,2E)-1,4,5-trimethyl-2-hexen-1-yl]-4H-inden-4-ylidene]ethylidene]-1,3-cyclohexanediol, (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-dimethylhept-3-en-2-yl)-7a-methyldihydro-1H-inden-4(2H,5H,6H,7H,7aH)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, (1R,3S,Z)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5R,E)-5,6-Dimethylhept-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol
Pubchem:PUBCHEM:73707407
Id:6932752c-5e49-5fe0-8696-11ec7b176ac2
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Doxercalciferol's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Doxercalciferol.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Doxercalciferol.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.